The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
FGFR1 amplification and EGFR mutation in Chinese squamous cell lung cancer.
Zhigang Wei
No relevant relationships to disclose
Jie Wang
No relevant relationships to disclose
Hua Bai
No relevant relationships to disclose
Tongtong An
No relevant relationships to disclose
Zhijie Wang
No relevant relationships to disclose
Minglei Zhuo
No relevant relationships to disclose
Meina Wu
No relevant relationships to disclose
Lu Yang
No relevant relationships to disclose